{
    "nctId": "NCT03290651",
    "briefTitle": "Probiotics and Breast Health",
    "officialTitle": "Re-setting the Breast Microbiome to Lower Inflammation and Risk of Cancer.",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer Female",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "BASIC_SCIENCE",
    "enrollmentCount": 60,
    "primaryOutcomeMeasure": "Change in breast microbiota",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Women at high risk of developing breast cancer who have never had breast cancer (\u2265 25% lifetime risk and/or BRCA1 or BRCA2 positive) will be included in the high risk group, while female family members of cancer patients or friends of patients, as well as patients to the breast clinic who are seen for other reasons not related to cancer will be offered participation in the control group.\n\nExclusion Criteria:\n\n* Exclusion criteria include: immunosuppression (ongoing high dose steroids, immunosuppressive condition such as HIV), personal history of breast cancer, patients declining needle aspiration biopsy or probiotic/placebo treatment, ongoing daily oral probiotic treatment at time of diagnosis. Patients on chronic or recent (within 2 weeks) antibiotic therapy will also be excluded.",
    "sex": "FEMALE",
    "minimumAge": "N/A",
    "stdAges": "CHILD, ADULT, OLDER_ADULT"
}